Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

Drugs.com Recognizes American Pharmacists Month

American pharmacist with senior man in pharmacy

Pharmacists Recognized for Their Valuable Role in Healthcare October is a special month here at Drugs.com – it’s American Pharmacists Month, spearheaded by the American Pharmacists Association (APhA). We are pharmacists ourselves, so naturally we like to take time this month to recognize the many pharmacists in the U.S. that work to improve patient care, […]

Drugs.com Receives Fourth Webby Nomination!

We are extremely proud to announce that Drugs.com has been nominated for the prestigious Webby Awards. Kudos to the hard working team! This is their fourth nomination in five years. To yet again be judged among the Internet’s top 5 health web sites is indeed an honor. But wait, there’s more… we need your vote! The […]

Drugs.com Pill Reminder featured on Fox Television Orlando

Our popular Pill Reminder app was featured on WOFL Fox 35 Orlando recently. Here’s what they had to say… “People need to take a medicine to keep that blood pressure down and it’s hard to motivate them,” said Dr. Timothy Hendrix of Centra Care. “It’s hard to remind them to take that everyday if they’re […]

Transparency in Clinical Trials: A New Paradigm Shift?

The British Medical Journal (BMJ), a leading, peer-reviewed medical journal, has announced that beginning in January 2013 it will require all authors of drug or device clinical trials who publish in BMJ – whether industry-funded or not – to provide detailed scientific study data to anyone with a reasonable request. Although the policy specifics are […]

Q2 2012 Drug Sales Data Released: Loss of Patent Protection Has Significant Effect

The latest U.S. drug sales data has been released by Drugs.com. Proton-pump inhibitors, antipsychotics, asthma therapeutics and statins remain the top selling categories. Plavix and Seroquel dipped in the second quarter due to loss of patent protection. Other top brands such as Singulair, Actos and Diovan are also due to be impacted by year’s end. […]

July 13 Webinar – FDA’s Safety Monitoring of Approved Vaccines

FDA’s Center for Biologics Evaluation and Research will host a 30-minute webinar on the agency’s efforts to ensure the safety of vaccines. There will be an opportunity to ask questions following the presentation on July 13, 2010, at 2:00 p.m. EDT. More information is available here: http://www.drugs.com/fda-consumer/july-13-webinar-fda-s-safety-monitoring-of-approved-vaccines-147.html See also, timely FDA Consumer Updates here: http://www.drugs.com/fda-consumer

Drugs.com receives another Webby nomination

voteforus_black

We are extremely proud to announce that Drugs.com has been nominated for a second prestigious Webby Award. To be judged among the Internet’s top 5 health web sites is indeed an honor. The Webby People’s Voice Awards is also one of the few major awards that invite the public to participate by allowing you to […]